• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素与天然黄酮类化合物联合对临床产超广谱β-内酰胺酶(ESBL)肺炎克雷伯菌的抗菌活性

Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae.

作者信息

Lin Rong-Dih, Chin Yi-Ping, Lee Mei-Hsien

机构信息

Department of Internal Medicine, Ho-Ping Branch, Taipei City Hospital, Taipei 100, Taiwan.

出版信息

Phytother Res. 2005 Jul;19(7):612-7. doi: 10.1002/ptr.1695.

DOI:10.1002/ptr.1695
PMID:16161024
Abstract

Extended-spectrum beta-lactamases (ESBLs) are plasmid-mediated class A enzymes commonly found in the family Enterobacteriaceae, mainly in Klebsiella pneumoniae. Flavonoids have also been reported to possess antimicrobial activity. In this study, the in vitro activities of 18 antibiotics and 12 flavonoids against 20 ESBL-producing K. pneumoniae isolates were evaluated. All of these isolates were susceptible to imipenem and cefmetazole, but were resistant to ampicillin, ampicillin/sulbactam, aztreonam, cefazolin, cefoperazone, cefotaxime, ceftazidime, ceftriaxone, cefuroxime, piperacillin and ticarcillin. Susceptibilities to amikacin, amoxicillin/clavulanate, cefoxitin, ciprofloxacin and gentamicin were variable. Myricetin, a flavonol, inhibited ESBL-producing K. pneumoniae isolates at a high minimum inhibitory concentration (MIC) (MIC(90) value 256 mg/mL), but exhibited significant synergic activity against ESBL-producing K. pneumoniae in separate combination with amoxicillin/clavulanate, ampicillin/sulbactam and cefoxitin. Because of the low-toxic nature of flavonoids, the combination of antibiotics and flavonoids is a potential new strategy for developing therapies for infections caused by ESBL-producing bacteria in the future.

摘要

超广谱β-内酰胺酶(ESBLs)是由质粒介导的A类酶,常见于肠杆菌科细菌中,主要是肺炎克雷伯菌。据报道,黄酮类化合物也具有抗菌活性。在本研究中,评估了18种抗生素和12种黄酮类化合物对20株产ESBLs肺炎克雷伯菌分离株的体外活性。所有这些分离株对亚胺培南和头孢美唑敏感,但对氨苄西林、氨苄西林/舒巴坦、氨曲南、头孢唑林、头孢哌酮、头孢噻肟、头孢他啶、头孢曲松、头孢呋辛、哌拉西林和替卡西林耐药。对阿米卡星、阿莫西林/克拉维酸、头孢西丁、环丙沙星和庆大霉素的敏感性各不相同。杨梅素,一种黄酮醇,在高最低抑菌浓度(MIC)(MIC90值为256mg/mL)时抑制产ESBLs肺炎克雷伯菌分离株,但与阿莫西林/克拉维酸、氨苄西林/舒巴坦和头孢西丁单独联合使用时,对产ESBLs肺炎克雷伯菌表现出显著的协同活性。由于黄酮类化合物的低毒性,抗生素与黄酮类化合物联合使用是未来开发产ESBLs细菌感染治疗方法的一种潜在新策略。

相似文献

1
Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae.抗生素与天然黄酮类化合物联合对临床产超广谱β-内酰胺酶(ESBL)肺炎克雷伯菌的抗菌活性
Phytother Res. 2005 Jul;19(7):612-7. doi: 10.1002/ptr.1695.
2
[Effect of inoculum size on sensitivity and specificity of the double-disk synergy test for the detection of wide-spectrum beta-lactamases].[接种量对双纸片协同试验检测超广谱β-内酰胺酶的敏感性和特异性的影响]
Lijec Vjesn. 2001 Nov-Dec;123(11-12):293-6.
3
Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.产超广谱β-内酰胺酶肺炎克雷伯菌和大肠埃希菌的抗菌药敏性
Isr Med Assoc J. 2005 May;7(5):298-301.
4
In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.16种抗菌药物对台湾两家地区医院产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌临床分离株的体外活性
J Microbiol Immunol Infect. 2006 Feb;39(1):59-66.
5
Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.浙江省产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌的流行病学及耐药性研究
Chin Med J (Engl). 2002 Oct;115(10):1479-82.
6
Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.肺炎克雷伯菌中质粒介导的AmpCβ-内酰胺酶和超广谱β-内酰胺酶基因的接合转移及基因分型
Chin Med J (Engl). 2009 May 5;122(9):1092-6.
7
Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi.新德里一家主要医院肺炎克雷伯菌产超广谱β-内酰胺酶(ESBLs)菌株的抗菌药敏模式及流行情况
J Commun Dis. 2004 Mar;36(1):17-26.
8
In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.头孢吡肟、亚胺培南、替加环素和庆大霉素单独及联合使用时对产超广谱β-内酰胺酶的肺炎克雷伯菌和大肠埃希菌的体外活性。
Pharmacotherapy. 2008 Mar;28(3):295-300. doi: 10.1592/phco.28.3.295.
9
Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.产超广谱β-内酰胺酶肺炎克雷伯菌对非β-内酰胺类抗菌药物的交叉耐药性
Am J Clin Pathol. 2003 Aug;120(2):265-7. doi: 10.1309/EF69-VNDL-VPWV-E4QV.
10
Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.头孢吡肟与产质粒介导的AmpC型β-内酰胺酶的肺炎克雷伯菌试验中的接种物效应
J Antimicrob Chemother. 2004 Dec;54(6):1130-3. doi: 10.1093/jac/dkh462. Epub 2004 Oct 14.

引用本文的文献

1
Inhibitory Potential of FB1-1 Cell-Free Supernatant against Carbapenem-Resistant Drug Resistance Spread.FB1-1无细胞上清液对碳青霉烯耐药性传播的抑制潜力
Microorganisms. 2024 Jun 14;12(6):1203. doi: 10.3390/microorganisms12061203.
2
Medicinal plant Miconia albicans synergizes with ampicillin and ciprofloxacin against multi-drug resistant Acinetobacter baumannii and Staphylococcus aureus.药用植物白蔓蒿与氨苄西林和环丙沙星协同作用,对抗多药耐药鲍曼不动杆菌和金黄色葡萄球菌。
BMC Complement Med Ther. 2023 Oct 23;23(1):374. doi: 10.1186/s12906-023-04147-w.
3
Identification of potential flavonoid compounds as antibacterial therapeutics against Klebsiella pneumoniae infection using structure-based virtual screening and molecular dynamics simulation.
利用基于结构的虚拟筛选和分子动力学模拟鉴定潜在的黄酮类化合物作为抗肺炎克雷伯菌感染的抗菌治疗剂。
Mol Divers. 2024 Oct;28(5):3111-3128. doi: 10.1007/s11030-023-10738-z. Epub 2023 Oct 6.
4
Metabolic profiling of UHPLC-HRMS-MS with computer-assisted structure elucidation and its antimicrobial activity.采用计算机辅助结构解析的超高效液相色谱-高分辨质谱-质谱联用技术进行代谢物谱分析及其抗菌活性研究。
Front Plant Sci. 2023 May 9;14:1138913. doi: 10.3389/fpls.2023.1138913. eCollection 2023.
5
Quercetin: Synergistic Interaction with Antibiotics against Colistin-Resistant .槲皮素:与抗生素对耐黏菌素菌的协同相互作用
Antibiotics (Basel). 2023 Apr 12;12(4):739. doi: 10.3390/antibiotics12040739.
6
Antibacterial Activity from L. Leaves and Flavones Enriched Phase.来自罗勒叶及富含黄酮相的抗菌活性。
Pharmaceutics. 2022 Aug 26;14(9):1796. doi: 10.3390/pharmaceutics14091796.
7
Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms.植物提取物对炭疽生物剂炭疽芽孢杆菌和新兴超级细菌的抗生素耐药性修饰能力:协同机制综述。
Ann Clin Microbiol Antimicrob. 2021 Dec 2;20(1):79. doi: 10.1186/s12941-021-00485-0.
8
Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens.探索植物化学物质以对抗微生物病原体中的抗生素耐药性
Front Pharmacol. 2021 Jul 21;12:720726. doi: 10.3389/fphar.2021.720726. eCollection 2021.
9
Myricetin as an Antivirulence Compound Interfering with a Morphological Transformation into Coccoid Forms and Potentiating Activity of Antibiotics against .杨梅素作为一种抗毒化合物,可干扰形态转化为球形,并增强抗生素对. 的活性。
Int J Mol Sci. 2021 Mar 7;22(5):2695. doi: 10.3390/ijms22052695.
10
Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications.杨梅素的生物活性作用:从临床前证据到潜在的临床应用。
BMC Complement Med Ther. 2020 Aug 1;20(1):241. doi: 10.1186/s12906-020-03033-z.